CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing advanced drug delivery systems using metal-organic frameworks (MOFs) to target cancer treatments. By controlling the release of drugs at disease sites, it aims to improve treatment efficacy and reduce side effects through innovative materials and biotargeting techniques.
Cancers are the leading cause of death in the developed world, with populations facing a 30% chance of developing the disease by the age of 75.
As part of a concerted effort to open up new treatments and improve patients’ experiences with existing ones, the concept of drug delivery – using non-toxic carriers to transport medicines directly to the location of disease – has emerged.
Metal-organic frameworks (MOFs), porous materials comprised of organic linkers and metal joints, show considerable p…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
